Effect of partial liver resection on tumour growth

Journal of Hepatology

Volumn 25, Issue 1, 1996, Pages 109-121

  De Jong, Koert P ^a,b   Slooff, Maarten J H ^a   De Vries, Elisabeth G E ^b   Brouwers, Mark A M ^a   Terpstra, Onno T ^c  

^a Department of Surgery   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH REGULATION; LIVER BLOOD FLOW; LIVER REGENERATION; LIVER TUMOR; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; TUMOR GROWTH;

EID: 0030199282     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80336-9     Document Type: Review

References (173)

1. Alison MR. Regulation of hepatic growth. Physiol Rev. 66:1986;499-541.
2. Michalopoulos GK. Liver regeneration: molecular mechanisms of growth control. FASEB J. 4:1990;176-187.
3. Liu ML, Mars WM, Zarnegar R, Michalopoulos GK. Uptake and distribution of hepatocyte growth factor in normal and regenerating adult rat liver. Am J Pathol. 144:1994;129-140.
4. Steele G Jr, Osteen RT, Wilson RE, Brooks DC, Mayer RJ, Zamcheck N, Ravikumar TS. Patterns of failure after surgical cure of large liver tumors. A change in the proximate cause of death and a need for effective systemic adjuvant therapy. Am J Surg. 147:1984;554-559.
5. Butler J, Attiyeh FF, Daly JM. Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet. 162:1986;109-113.
6. Hughes KS, Simon R, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG, Maclean BJ, Foster JH, Daly JM, Fitzherbert D, Sugarbaker PH, Iwatsuki S, Starzl TE, Ramming KP, Longmire WP, O'Toole K, Petrelli NJ, Herrera L, Cady B, McDermott W, Nims T, Enker WE, Coppa GF, Blumgart LH, Bradpiece H, Urist M, Aldrete JS, Schlag P, Hohenberger P, Steele G, Hodgson WJ, Hardy TG, Harbora D, McPherson TA, Lim C, Dillon D, Happ R, Ripepi P, Villella E, Rossi RL, Remine SG, Oster M, Connolly DP, Abrams J, Aljurf A, Hobbs KEF, Li MKW, Howard T, Lee E. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery. 100:1986;278-284.
7. Nordlinger B, Quilichini MA, Parc R, Hannoun L, Delva E, Huguet C. Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg. 205:1987;256-263.
8. Bozzetti F, Doci R, Bignami P, Morabito A, Gennari L. Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach. Ann Surg. 205:1987;264-270.
9. Fortner JG. Recurrence of colorectal cancer after hepatic resection. Am J Surg. 155:1988;378-382.
10. Holm A, Bradley E, Aldrete JS. Hepatic resection of metastasis from colorectal carcinoma. Morbidity, mortality, and pattern of recurrence. Ann Surg. 209:1989;428-434.
11. Steele G Jr, Bleday R, Mayer RJ, Lindblad A, Petrelli N, Weaver D. A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. J Clin Oncol. 9:1991;1105-1112.
12. Cady B, Stone MD, McDermott WV Jr, Jenkins RL, Bothe A Jr, Lavin PT, Lovett EJ, Steele GD Jr. Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg. 127:1992;561-568.
13. Yamaguchi A, Kurosaka Y, Kanno M, Yonemura Y, Izumi R, Miwa K, Miyazaki I. Analysis of hepatic recurrence of colorectal cancer after resection of hepatic metastases. Int Surg. 78:1993;16-19.
14. Hughes KS, Simon R, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG, Maclean BJ, Foster JH, Daly JM, Fitzherbert D, Sugarbaker PH, Iwatsuki S, Starzl TE, Ramming KP, Longmire WP, O'Toole K, Petrelli NJ, Herrera L, Cady B, McDermott W, Nims T, Enker WE, Coppa GF, Blumgart LH, Bradpiece H, Urist M, Aldrete JS, Schlag P, Hohenberger P, Steele G Jr, Hodgson WJ, Hardy TG, Harbora D, McPherson TA, Lim C, Dillon D, Happ R, Ripepi P, Villella E, Rossi RL, Remine SG, Oster M, Connolly DP, Abrams J, Al-Jurf A, Hobbs KEF, Li MKW, Howard T, Lee E. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surgery. 103:1988;278-288.
15. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg. 19:1995;59-71.
16. Mizutani J, Hiraoka T, Yamashita R, Miyauchi Y. Promotion of hepatic metastases by liver resection in the rat. Br J Cancer. 65:1992;794-797.
17. Ikeda Y, Matsumata T, Takenaka K, Sasaki O, Soejima K, Sugimachi K. Preliminary report of tumor metastasis during liver regeneration after hepatic resection in rats. Eur J Surg Oncol. 21:1995;188-190.
18. Murphy P, Alexander P, Senior PV, Fleming J, Kirkham N, Taylor I. Mechanisms of organ selective tumour growth by bloodborne cancer cells. Br J Cancer. 57:1988;19-31.
19. Fisher B, Fisher ER. Experimental studies of factors influencing hepatic metastases. II. Effect of partial hepatectomy. Cancer. 12:1959;929-932.
20. Hart IR, Saini A. Biology of tumour metastasis. Lancet. 339:1992;1453-1457.
21. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and anglogenesis: an imbalance of positive and negative regulation. Cell. 64:1991;327-336.
22. Ichihashi H, Mabuchi H, Suenaga M, Kondo T. Liver regeneration and tumor growth in the rat after partial hepatectomy. Jpn J Surg. 14:1984;510-514.
23. Seglen PO, Saeter G, Schwarze PE. Liver tumor promoters stimulate growth of transplanted hepatocellular carcinomas. Hepatology. 12:1990;295-300.
24. Asaga T, Suzuki K, Umeda M, Sugimasa Y, Takemiya S, Okamoto T. The enhancement of tumor growth after partial hepatectomy and the effect of sera obtained from hepatectomized rats on tumor cell growth. Jpn J Surg. 21:1991;669-675.
25. Leith JT, Padfield G, Michelson S. Effects of partial hepatectomy on the growth characteristics and hypoxic fractions of xenografted DLD-2 human colon cancers. Radiat Res. 132:1992;263-268.
26. Panis Y, Ribeiro J, Chretien Y, Nordlinger B. Dormant liver metastases: an experimental study. Br J Surg. 79:1992;221-223.
27. de Jong KP, Lont HE, Bijma AM, van Veen ML, Brouwers MAM, de Vries EGE, Marquet RL, Slooff MJH, Terpstra OT. The effect of partial hepatectomy on tumor growth in rats: in vivo and in vitro studies. Hepatology. 22:1995;1263-1272.
28. Castillo MH, Doerr RJ, Paolini N Jr, Cohen S, Goldrosen M. Hepatectomy prolongs survival of mice with induced liver metastases. Arch Surg. 124:1989;167-169.
29. Doerr R, Castillo M, Evans P, Paolini N, Goldrosen M, Cohen SA. Partial hepatectomy augments the liver's antitumor response. Arch Surg. 124:1989;170-174.
30. Lautt WW, Legare DJ, Ezzat WR. Quantitation of the hepatic arterial buffer response to graded changes in portal blood flow. Gastroenterology. 98:1990;1024-1028.
31. Mathie RT, Wheatley AM, Blumgart LH. Liver blood flow: physiology, measurement and clinical relevance. Blumgart LH. Surgery of the liver and biliary tract. 1994;95-110 Churchill Livingstone, Edinburgh.
32. Hanna SS, Pagliarello G, Ing A. Liver blood flow after major hepatic resection. Can J Surg. 31:1988;363-367.
33. Kahn D, van Hoorn Hickman R, Terblanche J. Liver blood flow after partial hepatectomy in the pig. J Surg Res. 37:1984;290-294.
34. Blumgart LH. Liver atrophy, hypertrophy and regenerative hyperplasia in the rat: the relevance of blood flow. Porter R, Whelan J. Hepatotrophic factors. 1978;181-214 Elsevier/Excerpta Medica, Amsterdam.
35. Karran SJ, Eagles CJ, Fleming JS, Ackery DM. In vivo measurement of liver perfusion in the normal and partially hepatectomized rat using Tc-99m sulfur colloid. J Nucl Med. 20:1979;26-31.
36. Starzl TE, Porter KA, Francavilla A. The Eck fistula in animals and humans. Curr Probl Surg. 20:1983;687-752.
37. Lin G, Lunderquist A, Hagerstrand I, Boijsen E. Postmortem examination of the blood supply and vascular pattern of small liver metastases in man. Surgery. 96:1984;517-526.
38. Haugeberg G, Strohmeyer T, Lierse W, Bocker W. The vascularization of liver metastases. Histological investigation of gelatine-injected liver specimens with special regard to the vascularization of micrometastases. J Cancer Res Clin Oncol. 114:1988;415-419.
39. Ridge JA, Bading JR, Gelbard AS, Benua RS, Daly JM. Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein. Cancer. 59:1987;1547-1553.
40. Taniguchi H, Daidoh T, Shioaki Y, Takahashi T. Blood supply and drug delivery to primary and secondary human liver cancers studied with in vivo bromodeoxyuridine labeling. Cancer. 71:1993;50-55.
41. Ackerman NB. Experimental studies on the role of the portal circulation in hepatic tumor vascularity. Cancer. 58:1986;1653-1657.
42. Cagol PP, Da Pian PP, Merkel C, Pilati PL, Pasqual EM, Talenti E, Lise M. Vascularization of experimental liver metastases. 1 Blood supply and vascular patterns. J Exp Clin Cancer Res. 58:1989;1653-1657.
43. Archer SG, Gray BN. Vascularization of small liver metastases. Br J Surg. 76:1989;545-548.
44. Cagol PP, Da Pian PP, Merkel C, Pilati PL, Pasqual EM, Prevaldi C, Lise M. Vascularization of experimental liver metastases. 2 Blood flow. J Exp Clin Cancer Res. 8:1989;137-142.
45. Stribley KV, Gray BN, Chmiel RL, Heggie JC, Bennett RC. Internal radiotherapy for hepatic metastases II: The blood supply to hepatic metastases. J Surg Res. 34:1983;25-32.
46. Sporn MB, Roberts AB. Peptide growth factors are multi-functional. Nature. 332:1988;217-219.
47. Sporn MB, Roberts AB. Peptide growth factors and inflammation, tissue repair and cancer. J Clin Invest. 78:1986;329-332.
48. Goustin AS, Leof EB, Shipley GD, Moses HL. Growth factors and cancer. Cancer Res. 46:1986;1015-1029.
49. Sporn MB, Roberts AB. Autocrine growth factors and cancer. Nature. 313:1985;745-747.
50. Lahm H, Suardet L, Laurent PL, Fischer JR, Ceyhan A, Givel JC, Odartchenko N. Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha. Br J Cancer. 65:1992;341-346.
51. Ziober BL, Willson JK, Hymphrey LE, Childress-Fields K, Brattain MG. Autocrine transforming growth factor-alpha is associated with progression of transformed properties in human colon cancer cells. J Biol Chem. 268:1993;691-698.
52. Derynck R. The physiology of transforming growth factor-alpha. Adv Cancer Res. 58:1992;27-52.
53. Marti U, Burwen SJ, Jones AL. Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: an update. Hepatology. 9:1989;126-138.
54. Olsen PS, Boesby S, Kirkegaard P, Therkelsen K, Almdal T, Poulsen SS, Nexo E. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology. 8:1988;992-996.
55. Francavilla A, Ove P, Polimeno L, Sciascia C, Coetzee ML, Starzl TE. Epidermal growth factor and proliferation in rat hepatocytes in primary culture isolated at different times after partial hepatectomy. Cancer Res. 46:1986;1318-1323.
56. Vesey DA, Selden AC, Woodman AC, Hodgson HJF. Effect of in vivo administration of an antibody to epidermal growth factor on the rapid increase in DNA synthesis induced by partial hepatectomy in the rat. Gut. 33:1992;831-835.
57. St Hilaire RJ, Hradek GT, Jones AL. Hepatic sequestration and biliary secretion of epidermal growth factor: evidence for a high-capacity uptake system. Proc Natl Acad Sci USA. 80:1983;3797-3801.
58. Cornell RP. Gut-derived endotoxin elicits hepatotrophic factor secretion for liver regeneration. Am J Physiol. 249:1985;R551-R562.
59. Mead JE, Fausto N. Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA. 86:1989;1558-1562.
60. Russell WE, Dempsey PJ, Sitaric S, Peck AJ, Coffey RJ. Transforming growth factor-alpha (TGFalpha) concentrations increase in regenerating rat liver: evidence for a delayed accumulation of mature TGFalpha. Endocrinology. 133:1993;1731-1738.
61. Untawale S, Zorbas MA, Hodgson CP, Coffey RJ, Gallick GE, North SM, Wildrick DM, Olive M, Blick M, Yeoman LC, Boman BM. Transforming growth factor-alpha production and autoinduction in a colorectal carcinoma cell line (DiFi) with an amplified epidermal growth factor receptor gene. Cancer Res. 53:1993;1630-1636.
62. Koretz K, Schlag P, Moller P. Expression of epidermal growth factor receptor in normal colorectal mucosa, adenoma, and carcinoma. Virchows Arch A Pathol Anat. 416:1990;343-349.
63. Steele RJ, Kelly P, Ellul B, Eremin O. Epidermal growth factor receptor expression in colorectal cancer. Br J Surg. 77:1990;1352-1354.
64. Kluftinger AM, Robinson BW, Quenville NF, Finley RJ, Davis NL. Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancer. Surg Oncol. 1:1992;97-105.
65. Borlinghaus P, Wieser S, Lamerz R. Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor content in normal and carcinomatous gastric and colonic tissue. Clin Invest. 71:1993;903-907.
66. Radinsky R, Risin S, Fan D, Dong Z, Bielenberg D, Bucana CD, Fidler IJ. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res. 1:1995;19-31.
67. Liu C, Woo A, Tsao MS. Expression of transforming growth factor-alpha in primary human colon and lung carcinomas. Br J Cancer. 62:1990;425-429.
68. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH. Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res. 47:1987;707-712.
69. Stoscheck CM, King LE Jr. Role of epidermal growth factor in carcinogenesis. Cancer Res. 46:1986;1030-1037.
70. Brachmann R, Lindquist PB, Nagashima M, Kohr W, Lipari T, Napier M, Derynck R. Transmembrane TGF-alpha precursors activate EGF/TGF-alpha receptors. Cell. 56:1989;691-700.
71. Wong ST, Winchell LF, McCune BK, Earp HS, Teixido J, Massague J, Herman B, Lee DC. The TGF-alpha precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction. Cell. 56:1989;495-506.
72. Massague J, Cheifetz S, Laiho M, Ralph DA, Weis FM, Zentella A. Transforming growth factor-beta. Cancer Surv. 12:1992;81-103.
73. Braun L, Mead JE, Panzica M, Mikumo R, Bell GI, Fausto N. Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci USA. 85:1988;1539-1543.
74. Russell WE, Coffey RJ, Ouellette AJ, Moses HL. Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA. 85:1988;5126-5130.
75. Francavilla A, Azzarone A, Carrieri G, Scotti-Foglieni C, Zeng QH, Cillo U, Porter K, Starzl TE. Effect on the canine Eck fistula liver of intraportal TGF-beta alone or with hepatic growth factors. Hepatology. 16:1992;1267-1270.
76. Bursch W, Oberhammer F, Jirtle RL, Askari M, Sedivy R, Grasl-Kraupp B, Purchio AF, Schulte-Hermann R. Transforming growth factor-beta 1 as a signal for induction of cell death by apoptosis. Br J Cancer. 67:1993;531-536.
77. Manning AM, Williams AC, Game SM, Paraskeva C. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta. Oncogene. 6:1991;1471-1476.
78. Markowitz SD, Myeroff L, Cooper MJ, Traicoff J, Kochera M, Lutterbauch J, Swiriduk M, Willson JKV. A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene. J Clin Invest. 93:1994;1005-1013.
79. Hoosein NM, McKnight MK, Levine AE, Mulder KM, Childress KE, Brattain DE, Brattain MG. Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1. Exp Cell Res. 181:1989;442-453.
80. Lahm H, Petral-Malec D, Yilmaz-Ceyhan A, Fischer JR, Lorenzoni M, Givel JC, Odartchenko N. Growth stimulation of a human colorectal carcinoma cell line by interleukin-1 and -6 and antagonistic effects of transforming growth factor beta 1. Eur J Cancer. 28A:1992;1894-1899.
81. Naylor MS, Stamp GW, Balkwill FR. Investigation of cytokine gene expression in human colorectal cancer. Cancer Res. 50:1990;4436-4440.
82. Coffey RJ, Goustin AS, Soderquist AM, Shipley GD, Wolfshohl J, Carpenter G, Moses HL. Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model. Cancer Res. 47:1987;4590-4594.
83. Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF, Sporn MB. Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci USA. 82:1985;119-123.
84. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 16:1995;3-34.
85. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev. 16:1995;143-163.
86. Baserga R. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res. 55:1995;249-252.
87. Murphy LJ, Bell GI, Friesen HG. Tissue distribution of insulin-like growth factor I and II messenger ribonucleic acid in the adult rat. Endocrinology. 120:1987;1279-1282.
88. Russell WE, D'Ercole AJ, Underwood LE. Somatomedin C/insulin-like growth factor I during liver regeneration in the rat. Am J Physiol. 248:1985;E618-E623.
89. Norstedt G, Levinovitz A, Moller C, Eriksson LC, Andersson G. Expression of insulin-like growth factor I (IGF-I) and IGF-II mRNA during hepatic development, proliferation and carcinogenesis in the rat. Carcinogenesis. 9:1988;209-213.
90. Unterman TG, Phillips LS. Circulating somatomedin activity during hepatic regeneration. Endocrinology. 119:1986;185-192.
91. Ghahary A, Minuk GY, Luo J, Gauthier T, Murphy LJ. Effects of partial hepatectomy on hepatic insulin-like growth factor binding protein-1 expression. Hepatology. 15:1992;1125-1131.
92. Lee J, Greenbaum L, Haber BA, Nagle D, Lee V, Miles V, Mohn KL, Bucan M, Taub R. Structure and localization of the IGFBP-1 gene and its expression during liver regeneration. Hepatology. 19:1994;656-665.
93. Scott CD, Baxter RC. Insulin-like growth factor-II/mannose-6-phosphate receptors are increased in hepatocytes from regenerating rat liver. Endocrinology. 126:1990;2543-2549.
94. Caro JF, Poulos J, Ittoop O, Pories WJ, Flickinger EG, Sinha MK. Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver. J Clin Invest. 81:1988;976-981.
95. Pollak MN, Perdue JF, Margolese RG, Baer K, Richard M. Presence of somatomedin receptors on primary human breast and colon carcinomas. Cancer Lett. 38:1987;223-230.
96. Guo YS, Narayan S, Yallampalli C, Singh P. Characterization of insulinlike growth factor I receptors in human colon cancer. Gastroenterology. 102:1992;1101-1108.
97. Tricoli JV, Rall LB, Karakousis CP, Herrera L, Petrelli NJ, Bell GI, Shows TB. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res. 46:1986;6169-6173.
98. Durrant LG, Watson SA, Hall A, Morris DL. Co-stimulation of gastrointestinal tumour cell growth by gastrin, transforming growth factor alpha and insulin like growth factor-I. Br J Cancer. 63:1991;67-70.
99. Koenuma M, Yamori T, Tsuruo T. Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn J Cancer Res. 80:1989;51-58.
100. Singh P, Rubin N. Insulinlike growth factors and binding proteins in colon cancer. Gastroenterology. 105:1993;1218-1237.
101. Kan M, Huang JS, Mansson PE, Yasumitsu H, Carr B, McKeehan WL. Heparin-binding growth factor type 1 (acidic fibroblast growth factor): a potential biphasic autocrine and paracrine regulator of hepatocyte regeneration. Proc Natl Acad Sci USA. 86:1989;7432-7436.
102. Marsden ER, Hu Z, Fujio K, Nakatsukasa H, Thorgeirsson SS, Evarts RP. Expression of acidic fibroblast growth factor in regenerating liver and during hepatic differentiation. Lab Invest. 67:1992;427-433.
103. Folkman J, Klagsburn M. Angiogenic factors. Science. 235:1987;442-447.
104. Sunderkotter C, Goebeler M, Schulze-Osthoff K, Bhardwaj R, Sorg C. Macrophage-derived angiogenesis factors. Pharmacol Ther. 51:1991;195-216.
105. Leith JT, Michelson S. Effects of administration of basic fibroblast growth factor on hypoxic fractions in xenografted DLD-2 human tumours: time dependence. Br J Cancer. 68:1993;727-731.
106. Leith JT, Papa G, Quaranto L, Michelson S. Modification of the volumetric growth responses and steady-state hypoxic fractions of xenografted DLD-2 human colon carcinomas by administration of basic fibroblast growth factor or suramin. Br J Cancer. 66:1992;345-348.
107. New BA, Yeoman LC. Identification of basic fibroblast growth factor sensitivity and receptor and ligand expression in human colon tumor cell lines. J Cell Physiol. 150:1992;320-326.
108. Matsumoto K, Nakamura T. Hepatocyte growth factor: molecular structure and implications for a central role in liver regeneration. J Gastroenterol Hepatol. 6:1991;509-519.
109. Jiang WG, Hallett MB, Puntis MC. Hepatocyte growth factor/scatter factor, liver regeneration and cancer metastasis. Br J Surg. 80:1993;1368-1373.
110. Schirmacher P, Geerts A, Pietrangelo A, Dienes HP, Rogler CE. Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology. 15:1992;5-11.
111. Kinoshita T, Hirao S, Matsumoto K, Nakamura T. Possible endocrine control by hepatocyte growth factor of liver regeneration after partial hepatectomy. Biochem Biophys Res Commun. 177:1991;330-335.
112. Lindroos PM, Zarnegar R, Michalopoulos GK. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology. 13:1991;743-750.
113. Kaneko A, Hayashi N, Tanaka Y, Ito T, Kasahara A, Kubo M, Mukuda T, Fusamoto H, Kamada T. Changes in serum human hepatocyte growth factor levels after transcatheter arterial embolization and partial hepatectomy. Am J Gastroenterol. 87:1992;1014-1017.
114. Zioncheck TF, Richardson L, DeGuzman GG, Modi NB, Hansen SEG, Godowski PJ. The pharmacokinetics, tissue localization, and metabolic processing of recombinant human hepatocyte growth factor after intravenous administration in rats. Endocrinology. 134:1994;1879-1887.
115. Wolf HK, Zarnegar R, Michalopoulos GK. Localization of hepatocyte growth factor in human and rat tissues: an immunohistochemical study. Hepatology. 14:1991;488-494.
116. Jiang WG, Lloyds D, Puntis MCA, Nakamura T, Hallett MB. Regulation of spreading and growth of colon cancer cells by hepatocyte growth factor. Clin Exp Metastasis. 11:1993;235-242.
117. Sunitha I, Meighen DL, Hartman DP, Thompson EW, Byers SW, Avigan MI. Hepatocyte growth factor stimulates invasion across reconstituted basement membranes by a new human small intestinal cell line. Clin Exp Metastasis. 12:1994;143-154.
118. Di Renzo MF, Narsimhan RP, Olivero M, Bretti S, Giordano S, Medico E, Gaglia P, Zara P, Comoglio PM. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene. 6:1991;1997-2003.
119. Goss JA, Mangino MJ, Callery MP, Flye MW. Prostaglandin E2 downregulates Kupffer cell production of IL-1 and IL-6 during hepatic regeneration. Am J Physiol. 264:1993;G601-G608.
120. Weber J, Yang JC, Topalian SL, Parkinson DR, Schwartzentruber DS, Ettinghausen SE, Gunn H, Mixon A, Kim H, Cole D, Levin R, Rosenberg SA. Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol. 11:1993;499-506.
121. Shirota K, LeDuy L, Yuan SY, Jothy S. Interleukin-6 and its receptor are expressed in human intestinal epithelial cells. Virchows Arch B Cell Pathol. 58:1990;303-308.
122. Fearon KC, McMillan DC, Preston T, Winstanley FP, Cruickshank AM, Shenkin A. Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer. Ann Surg. 213:1991;26-31.
123. Avery A, Paraskeva C, Hall P, Flanders KC, Sporn M, Moorghen M. TGF-beta expression in the human colon: differential immunostaining along crypt epithelium. Br J Cancer. 68:1993;137-139.
124. Satoh M, Yamazaki M. Tumor necrosis factor stimulates DNA synthesis of mouse hepatocytes in primary culture and is suppressed by transforming growth factor beta and interleukin 6. J Cell Physiol. 150:1992;134-139.
125. Beyer HS, Stanley M, Theologides A. Tumor necrosis factor-α increases hepatic DNA and RNA and hepatocyte mitosis. Biochem Int. 22:1990;405-410.
126. Akerman P, Cote P, Yang SQ, McClain C, Nelson S, Bagby GJ, Diehl AM. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol. 263:1992;G579-G585.
127. Satoh M, Adachi K, Suda T, Yamazaki M, Mizuno D. TNF-driven inflammation during mouse liver regeneration after partial hepatectomy and its role in growth regulation of liver. Mol Biother. 3:1991;136-147.
128. Bacon CM, Lawry J, Rees RC. TNF alpha protects SW742 human colon carcinoma cells against non-MHC-restricted cytolysis. Immunol Lett. 38:1993;215-222.
129. Thomas C, Nijenhuis AM, Dontje B, Daemen T, Scherphof GL. Tumoricidal response of liver macrophages isolated from rats bearing liver metastases of colon adenocarcinoma. J Leukoc Biol. 57:1995;617-623.
130. Bouwens L, Baekeland M, Wisse E. Importance of local proliferation in the expanding Kupffer cell population of rat liver after zymosan stimulation and partial hepatectomy. Hepatology. 4:1984;213-219.
131. Ukai K, Terashima K, Imai Y, Shinzawa H, Okuyama Y, Takahashi T, Ishikawa M. Proliferation kinetics of rat Kupffer cells after partial hepatectomy. Immunohistochemical and ultrastructural analysis. Acta Pathol Jpn. 40:1990;623-634.
132. Roh MS, Kahky MP, Oyedeji C, Klostergaard J, Wang L, Curley SA, Lotzova E. Murine Kupffer cells and hepatic natural killer cells regulate tumor growth in a quantitative model of colorectal liver metastases. Clin Exp Metastasis. 10:1992;317-327.
133. Miyahara S, Yokomuro K, Takahashi H, Kimura Y. Regeneration and the immune system. I. In vitro and in vivo activation of lymphocytes by liver regeneration and the role of Kupffer cells in stimulation. Eur J Immunol. 13:1983;878-883.
134. Ono M, Tanaka N, Orita K. Complete regression of mouse hepatoma transplanted after partial hepatectomy and the immunological mechanism of such regression. Cancer Res. 46:1986;5049-5053.
135. Gardner CR, Wasserman AJ, Laskin DL. Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity. Cancer Res. 47:1987;6686-6691.
136. Curran RD, Billiar TR, Kispert PH, Bentz BG, May MT, Simmons RL. Hepatocytes enhance Kupffer cell-mediated tumor cell cytostasis in vitro. Surgery. 106:1989;126-132.
137. Katsumoto F, Miyazaki K, Nakayama F. Stimulation of DNA synthesis in hepatocytes by Kupffer cells after partial hepatectomy. Hepatology. 9:1989;405-410.
138. Roh MS, Wang L, Oyedeji C, LeRoux ME, Curley SA, Pollock RE, Klostergaard J. Human Kupffer cells are cytotoxic against human colon adenocarcinoma. Surgery. 108:1990;400-404.
139. Vanderkerken K, Bouwens L, van Rooijen N, van den Berg K, Baekeland M, Wisse E. The role of Kupffer cells in the differentiation process of hepatic natural killer cells. Hepatology. 22:1995;283-290.
140. Bouwens L, Wisse E. Pit cells in the liver. Liver. 12:1992;3-9.
141. Vanderkerken K, Bouwens L, Wisse E. Characterization of a phenotypically and functionally distinct subset of large granular lymphocytes (pit cells) in rat liver sinusoids. Hepatology. 12:1990;70-75.
142. Bouwens L, Monden K, Vanderkerken K, van den Berg K, Wisse E. Effects of colon carcinoma tumors in rat liver on the composition and cytotoxic activity of hepatic pit cells. Knook DL, Wisse E. Cells of the hepatic sinusoid. 1993;548-550 Kupffer Cell Foundation, Rijswijk.
143. Bouwens L, Charels K, van Dale P, Wisse E. Sinusoidal cell reactions associated with colon cancer metastases in rat liver. Knook DL, Wisse E. Cells of the hepatic sinusoid II. 1989;237-238 Kupffer Cell Foundation, Rijswijk.
144. Winnock M, Garcia-Barcina M, Huet S, Bernard P, Saric J, Bioulac-Sage P, Gualde N, Balabaud C. Functional characterization of liver-associated lymphocytes in patients with liver metastasis. Gastroenterology. 105:1993;1152-1158.
145. Cornell RP, Liljequist BL, Bartizal KF. Depressed liver regeneration after partial hepatectomy of germ-free, athymic and lipopolysaccharide-resistant mice. Hepatology. 11:1990;916-922.
146. Cornell RP. Acute phase responses after acute liver injury by partial hepatectomy in rats as indicators of cytokine release. Hepatology. 11:1990;923-931.
147. Roesel J, Rigsby D, Bailey A, Alvarez R, Sanchez JD, Campbell V, Shrestha K, Miller DM. Stimulation of protooncogene expression by partial hepatectomy is not tissue-specific. Oncogene Res. 5:1989;129-136.
148. Stolar CJH, Anderson KD. Growth of mouse hepatoma following liver resection. J Pediatr Surg. 15:1980;513-516.
149. Namieno T, Takeichi N, Hata Y, Uchino J, Kobayashi H. Kinetic changes of liver regeneration and hepatocellular carcinoma cells after partial hepatectomy in rats. Gastroenterol Jpn. 26:1991;29-36.
150. Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM, Fidler IJ. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res. 48:1988;1943-1948.
151. Gutman M, Fidler IJ. Biology of human colon cancer metastasis. World J Surg. 19:1995;226-234.
152. Nicolson GL. Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis. Exp Cell Res. 204:1993;171-180.
153. Cross M, Dexter TM. Growth factors in development, transformation, and tumorigenesis. Cell. 64:1991;271-280.
154. Pardee AB. G1 events and regulation of cell proliferation. Science. 246:1989;603-608.
155. Wyllie AH. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev. 11:1992;95-103.
156. Evan GI, Littlewood TD. The role of c-myc in cell growth. Curr Opin Genet Dev. 3:1993;44-49.
157. 157 Koskinen PJ, Alitalo K. Role of myc amplification and overexpression in cell growth, differentiation and death. Semin Cancer Biol. 4:1993;3-12.
158. Resnicoff M, Abraham D, Yutanawiboonchai W, Rotman HL, Kajstura J, Rubin R, Zoltick P, Baserga R. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res. 55:1995;2463-2469.
159. Lane DP. Cancer. p53, guardian of the genome. Nature. 358:1992;15-16.
160. Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, Zehnbauer BA, Hamilton SR, Jones RJ. Inhibition of apoptosis during development of colorectal cancer. Cancer Res. 55:1995;1811-1816.
161. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 55:1995;237-241.
162. Goh HS, Chan CS, Khine K, Smith DR. p53 and behaviour of colorectal cancer. Lancet. 344:1994;233-234.
163. Chang F, Syrjanen S, Syrjanen K. Implications of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol. 13:1995;1009-1022.
164. Prehn RT. The inhibition of tumor growth by tumor mass. Cancer Res. 51:1991;2-4.
165. Steele G Jr, Ravikumar TS. Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg. 210:1989;127-138.
166. Fortner JG, Silva JS, Golbey RB, Cox EB, Maclean BJ. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg. 199:1984;306-316.
167. O'Connell MJ, Adson MA, Schutt AJ, Rubin J, Moertel CG, Ilstrup DM. Clinical trial of adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver. Mayo Clin Proc. 60:1985;517-520.
168. August DA, Sugarbaker PH, Ottow RT, Gianola FJ, Schneider PD. Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival. Ann Surg. 201:1985;210-218.
169. Patt YZ, McBride CM, Ames FC, Claghorn LJ, Cleary KR, Boddie AW, Charnsangavej C, Mavligit GM. Adjuvant perioperative hepatic arterial mitomycin C and floxuridine combined with surgical resection of metastatic colorectal cancer in the liver. Cancer. 59:1987;867-873.
170. Wagman LD, Kemeny MM, Leong L, Terz JJ, Hill LR, Beatty JD, Kokal WA, Riihimaki DU. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol. 8:1990;1885-1893.
171. Kemeny N, Conti JA, Sigurdson E, Cohen A, Seiter K, Lincer R, Niedzwiecki D, Botet J, Chapman D, Costa P, Budd A. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases. Cancer. 71:1993;1964-1971.
172. Bignami P, Doci R, Montalto F, Fissi S, di Bartolomeo M, Gennari L. Feasibility of intraportal chemotherapy with fluorouracil and folinic acid immediately after hepatic resection for colorectal metastases. Tumori. 81:1995;96-101.
173. Tamura J, Tanaka J, Fujita K, Yoshida M, Kasamatsu T, Arii S, Tobe T. Effect of anticancer agents on cell cycle of regenerating hepatocytes in rats. J Surg Res. 53:1992;218-226.